CMS Updates Deep Brain Stimulation Coverage Policy: What Billing Teams Need to Know About NCD 279

The Centers for Medicare & Medicaid Services (CMS) has modified National Coverage Determination (NCD) 279, governing Deep Brain Stimulation (DBS) for Essential Tremor and Parkinson's Disease. This update, effective March 12, 2026, clarifies the medical necessity criteria, patient qualification thresholds, and facility requirements that determine whether a DBS procedure will be covered under Medicare's Physicians' Services and Prosthetic Devices benefit categories.

Field	Detail
Payer	CMS
Policy	Deep Brain Stimulation for Essential Tremor and Parkinson's Disease
Policy Code	NCD 279
Change Type	Modified
Effective Date	2026-03-12
Impact Level	High
Specialties Affected	Neurosurgery, Neurology, Movement Disorder Clinics, Inpatient Facilities
Key Action	Audit DBS patient documentation against updated CMS criteria before submitting claims, particularly tremor severity ratings and PD staging scales.

---

CMS NCD 279: What Deep Brain Stimulation Coverage Actually Requires

DBS coverage under Medicare is not broad — it is tightly defined by target anatomy, diagnosis type, and patient-level criteria. CMS distinguishes coverage across two clinical pathways: thalamic Ventralis Intermedius Nucleus (VIM) stimulation and Subthalamic Nucleus (STN) or Globus Pallidus Interna (GPi) stimulation. Each pathway has its own set of required criteria, and conflating them in documentation is one of the fastest ways to generate a denial.

The foundational rule across both pathways: only FDA-approved DBS devices — or devices used under FDA-approved Category B Investigational Device Exemption (IDE) clinical trial protocols — are considered reasonable and necessary. Any claim involving an unapproved device will not clear medical necessity review.

---

CMS Coverage Criteria: Thalamic VIM Deep Brain Stimulation

Thalamic VIM DBS is covered for patients with Essential Tremor (ET) or Parkinsonian tremor. To meet CMS medical necessity, all three of the following conditions must be documented in the medical record:

#	Covered Indication Copy
1	Confirmed diagnosis — ET characterized by postural or kinetic hand tremors without other neurologic signs, or idiopathic Parkinson's Disease (PD) with at least two cardinal features (tremor, rigidity, or bradykinesia) that is tremor-dominant in presentation.
2	Tremor severity — Marked, disabling tremor rated at level 3 or 4 on the Fahn-Tolosa-Marin Clinical Tremor Rating Scale, or an equivalent validated scale, specifically in the extremity targeted for treatment. The tremor must cause significant limitation in daily activities despite optimal medical therapy — meaning conservative treatment failure must be documented.
3	Patient cooperation — The patient must demonstrate willingness and ability to cooperate during the conscious operative procedure, and during post-surgical evaluations, medication adjustments, and stimulator setting changes.

Each criterion needs to be explicitly addressed in pre-operative documentation. A tremor score that isn't tied to a named, validated scale is a documentation gap that medical reviewers will flag.

---

CMS Coverage Criteria: STN or GPi Deep Brain Stimulation for Parkinson's Disease

STN or GPi DBS covers a distinct clinical population — patients with advanced idiopathic PD who have failed or are inadequately managed with pharmacological therapy. CMS requires all five of the following:

1. PD diagnosis based on at least two cardinal features: tremor, rigidity, or bradykinesia.
2. Advanced idiopathic PD as determined using the Hoehn and Yahr staging scale or the Unified Parkinson's Disease Rating Scale (UPDRS) Part III motor subscale.
3. L-dopa responsiveness with clearly defined "on" periods — this must be documented through medication response history.
4. Persistent disabling symptoms or drug side effects despite optimal medical therapy, including dyskinesias, motor fluctuations, or disabling "off" periods.
5. Patient cooperation with the conscious operative procedure and ongoing post-surgical management.

For billing teams: if the clinical record doesn't reference the Hoehn and Yahr or UPDRS Part III by name, and doesn't document L-dopa response specifically, expect a medical necessity denial.

---

What CMS Explicitly Does NOT Cover Under NCD 279

CMS is equally clear about exclusions. DBS is not reasonable and necessary — and will not be covered — for ET or PD patients who have any of the following:

• Non-idiopathic Parkinson's disease or "Parkinson's Plus" syndromes (e.g., multiple system atrophy, progressive supranuclear palsy)
• Cognitive impairment, dementia, or depression that would worsen with or interfere with DBS benefit
• Current psychosis, alcohol abuse, or other substance abuse
• Structural lesions — basal ganglionic stroke, tumor, or vascular malformation — as the etiology of the movement disorder
• Previous movement disorder surgery within the affected basal ganglion
• Significant medical, surgical, neurologic, or orthopedic comorbidities that contraindicate DBS surgery or stimulation

These are hard exclusions, not factors to weigh. If any apply, DBS is non-covered — period.

---

Post-Implantation Restrictions That Affect Ongoing Care and Billing

Two post-implantation restrictions in NCD 279 have downstream billing implications that your clinical and billing teams both need to know:

• MRI is contraindicated for patients with implanted DBS systems. Any MRI ordered post-implantation may adversely affect the DBS system or surrounding brain tissue. If an MRI claim appears alongside a DBS patient's record, expect scrutiny — and ensure clinical staff are flagging this at the order level.
• Diathermy is contraindicated — this includes shortwave, microwave, and ultrasound diathermy. Billing for diathermy services on a DBS patient could trigger a coverage conflict.
• Cardiac pacemakers and other electronic implants require extreme caution and must be documented as a considered risk factor if present.

---

Facility and Provider Requirements Under NCD 279

CMS requires that both the neurosurgeon and the performing facility meet specific credentialing criteria for DBS lead implantation to be considered reasonable and necessary. The policy specifies that neurosurgeons must be properly trained in the procedure and have experience with the surgical management of DBS. Though the full facility criteria were truncated in the available policy summary, your compliance team should verify that credentialing documentation for performing surgeons is current and on file.

If a claim is submitted from a provider or facility that cannot demonstrate these qualifications, CMS has grounds to deny on medical necessity — even if the patient criteria are met.

---

Affected Codes

The NCD 279 policy document as published does not list specific CPT or HCPCS codes applicable to this coverage determination. This is not unusual for NCDs, which often operate at the coverage-determination level rather than the code-specific level. Applicable procedural codes for DBS — including implantation, programming, and replacement — should be mapped against this NCD through your payer's LCD (Local Coverage Determination) layer or direct CMS guidance.

Related ICD-10 Diagnosis Codes to Reference During Claim Prep:

While not enumerated in the NCD itself, the following diagnosis codes are directly relevant to the covered indications and should be verified against your MAC's LCDs:

Code	Description Copy
G20	Parkinson's disease
G25.0	Essential tremor
G25.1	Drug-induced tremor

Confirm with your MAC whether additional specificity codes are required, and do not use G25.1 for coverage under this NCD — drug-induced tremor is not an indicated condition under NCD 279.

---

What Your Billing Team Should Do

Copy Action Items

---